Skip to main content
  • Updated

(US and Canada) Scott Harrison, Chief Data Officer at Parkland Health and Hospital Systems, discusses with Andy Sajous, Field CTO, Central Region, AHEAD, what he wishes he'd known two years ago. Sajous suggests he would have probably taken a different approach and integrate systems for analy…

(Asia) Founded in 2016, Leapstack is the explorer of "RPA + AI" in healthcare insurance in China, offering services to regulatory bodies such as commercial insurance companies, medical insurance bureaus and audit departments with enterprise-level big data risk control solutions through the one-stop intelligent risk control platform powered by RPA+AI.

(US and Canada) The deal brings a fully automated and customer-friendly digital platform developed by Fabric, which was founded in 2015 and is headquartered in Brooklyn, New York, to a Cincinnati-based company that began selling life insurance door to door 134 years ago as The Western and Southern Life Insurance Company and is now one of the world's largest life insurance groups.

  • Updated

(US and Canada) Katia Walsh, PhD, Chief Global Strategy and AI Officer, Levi Strauss, speaks with Baz Khuti, President US, Modak, on the key global digital data and AI developments she expects in 2022. The first trend she identifies is the global acceleration of the use of digital data and A…

(US and Canada) Cochl is a deep-tech startup founded by audio and machine learning specialists to advance sound AI technologies. KOPRI, a research institute under the Korean Ministry of Oceans and Fisheries for scientific research on the polar regions, will investigate the use of sound AI to automate some of its repetitive tasks and derive meaningful insights from AI-based quantification of its time-series audio data for analyzing climate change, biodiversity, and other environmental metrics through collaborations with Cochl.

  • Updated

(US and Canada) Artificial Intelligence and Technology Collaboratories will offer pilot awardees access to a wealth of resources, translational services, and state-of the art facilities, including software and hardware platforms, data sets, and population study sites. Awardees will also be eligible to apply for US$10,000 in AWS credits.

 

  • Updated

(Europe) Collaborative efforts between Sanofi and Exscientia aim to accelerate drug discovery and improve clinical success. The new research collaboration will utilize Exscientia’s AI-based capabilities and personalized medicine platform from target identification through patient selection. Exscientia will receive an upfront cash payment of US$100 million with the potential of US$5.2 billion in total milestones plus tiered royalties.